SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
-12.11%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$454M
AUM Growth
+$454M
Cap. Flow
+$16.6M
Cap. Flow %
3.65%
Top 10 Hldgs %
94.65%
Holding
18
New
1
Increased
4
Reduced
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABBV icon
1
AbbVie
ABBV
$372B
$90.2M 19.89% 1,580,000
ARIA
2
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$82.1M 18.09% 12,850,000
BIIB icon
3
Biogen
BIIB
$19.4B
$80.7M 17.78% 310,000
MDCO
4
DELISTED
Medicines Co
MDCO
$55.7M 12.27% 1,752,000 +185,000 +12% +$5.88M
DGX icon
5
Quest Diagnostics
DGX
$20.3B
$41.1M 9.05% 575,000
PCRX icon
6
Pacira BioSciences
PCRX
$1.2B
$28.2M 6.21% 532,200
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.8M 4.13% 675,000
RPTP
8
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$12.5M 2.76% +2,725,000 New +$12.5M
ESPR icon
9
Esperion Therapeutics
ESPR
$448M
$10.7M 2.36% 633,000 +185,000 +41% +$3.13M
AEGR
10
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$9.55M 2.1% 2,580,000
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
$8.48M 1.87% 2,875,000 +2,175,000 +311% +$6.42M
SEEL
12
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$8.41M 1.85% 14,479,052 +7,954,547 +122% +$4.62M
VVUS
13
DELISTED
Vivus Inc
VVUS
$3.6M 0.79% 2,573,943
AVEO
14
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.13M 0.47% 2,313,759
RPRX
15
DELISTED
Repros Therapeutics Inc.
RPRX
$970K 0.21% 1,001,000
AMGN icon
16
Amgen
AMGN
$155B
-90,000 Closed -$14.6M
ANIP icon
17
ANI Pharmaceuticals
ANIP
$2.03B
-31,000 Closed -$1.4M